| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Other
|
Homo sapiens
|
BEDPE
|
Tze King Tan
|
||||
| GSE181214 |
H3K27ac HiChIP analysis in TL-Om1 cells
|
|
|
1 |
|
Tze King Tan | Nov 20, 2023 | |
| GSE181215 |
Requirement for TP73 in cancer cell maintenance and genetic alterations originating from its intragenic super-enhancer
|
|
25 |
|
Tze King Tan | Nov 20, 2023 | ||
| GSE199365 |
H3K27ac HiChIP analysis in BALL cells
|
|
|
5 | Tze King Tan | Aug 11, 2024 | ||
| GSE214018 |
Super-enhancer-driven PPP1R15B/CReP, regulated by C/EBPβ and YY1, is oncogenic in multiple myeloma [HiChIP I]
|
|
8 | Tze King Tan | Jun 25, 2024 | |||
| GSE214792 |
H3K27ac HiChIP analysis in GI-MEN DOX-ASCL1 cells
|
|
2 |
|
Tze King Tan | Nov 21, 2023 | ||
| GSE214796 |
ASCL1 a pioneer factor that induces subtype switching and characterizes adrenergic neuroblastoma
|
|
44 |
|
Tze King Tan | Nov 21, 2023 | ||
| GSE225937 |
H3K27ac Hi-ChIP analysis in TAL1-FKBP12 Jurkat cells
|
|
2 | Tze King Tan | Nov 20, 2023 | |||
| GSE225941 |
Regulatory mechanisms and context-dependent roles of TAL1 in TALL
|
|
75 |
|
Tze King Tan | Nov 20, 2023 | ||
| GSE230591 |
H3K27ac Hi-ChIP analysis in MOLT-4 and DND-41 cells.
|
|
|
6 | Tze King Tan | Jul 02, 2024 | ||
| GSE230594 |
Oncogenic roles of SWI/SNF chromatin remodeling factors: therapeutic targets in T-cell acute lymphoblastic leukemia
|
|
88 |
|
Tze King Tan | Jul 02, 2024 | ||
| GSE231965 |
TAL1 hijacks MYCN enhancer that induces MYCN expression and dependence on mevalonate pathway in T-cell acute lymphoblastic leukemia
|
|
34 |
|
Tze King Tan | Aug 16, 2023 | ||
| GSE267003 |
Super-enhancer-driven PPP1R15B/CReP, regulated by C/EBPβ and YY1, is oncogenic in multiple myeloma [HiChIP II]
|
|
8 | Tze King Tan | Jun 25, 2024 | |||
| GSE267004 |
Super-enhancer-driven PPP1R15B/CReP, regulated by C/EBPβ and YY1, is oncogenic in multiple myeloma
|
|
16 | Tze King Tan | Jun 25, 2024 |
